CHIH
Global X MSCI China Health Care ETF
NAV as of
4 Week: 13.09 - 14.06
52 Week: 12.54 - 19.42
Latest Closing Price
13.72
Premium / Discount
0.07
Expense Ratio
0.65%
Investment Objective
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI China Health Care 10/50 Index. The fund invests at least 80% of its total assets in the securities of the underlying index and in ADRs and GDRs based on the securities in the underlying index. The underlying index tracks the performance of companies in the MSCI China Index (the "parent index") that are classified in the health care sector, as defined by the index provider. The fund is non-diversified.
Main Fund Characteristics
Performance
| Period | Performance Returns(%) | Volatility(%) | Risk Adjusted Performance |
|---|---|---|---|
| YTD | -17.04 | 1.81 | -9.42 |
| 1 Day | -1.61 | 0.00 | 0.00 |
| 1 Week | 1.99 | 5.89 | 0.34 |
| 1 Month | -2.85 | 10.28 | -0.28 |
| 3 Months | -0.24 | 15.84 | -0.02 |
| 6 Months | -15.43 | 20.81 | -0.74 |
| 1 Year | 3.22 | 32.82 | 0.10 |
| 2 Years | -47.26 | 50.12 | -0.94 |
| 3 Years | -41.50 | 60.02 | -0.69 |
| 5 Years | 0.00 | 0.00 | 0.00 |
| 10 Years | 0.00 | 0.00 | 0.00 |
Price History
Annual Performance Return
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
| Price (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 31.7189 | 52.7628 | -19.3836 | -22.6702 |
| Nav (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| Rank | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 40.0000 | 25.0000 | 77.0000 | 28.0000 |
Dividend Frequency
Lastest Dividend
| Ex Date | Payment Date | Dividend Payout per unit |
|---|---|---|
| N.A | ||
Portfolio Data
Total Number of Holdings: 80
Number of Bond Holdings: 0
Number of Equity Holdings: 77
Total Market Value: 8,611,198
Portfolio Composition
Top 10 Holdings
| % Portfolio Weight | Shares Owned | Shares Changed | Market Value | ||
|---|---|---|---|---|---|
| 1 | CSPC Pharmaceutical Group Ltd | 12.7273 | 130,000 | 0 | 345,050 |
| 2 | Sino Biopharmaceutical Ltd | 9.8158 | 171,500 | 0 | 266,117 |
| 3 | WuXi Biologics (Cayman) Inc Registered Shs Unitary | 8.0556 | 19,740 | 0 | 218,394 |
| 4 | Sinopharm Group Co Ltd H | 6.7247 | 51,300 | 0 | 182,313 |
| 5 | Alibaba Health Information Technology Ltd | 6.1249 | 158,500 | 0 | 166,053 |
| 6 | 3SBio Inc | 4.3156 | 60,400 | 0 | 116,999 |
| 7 | Shandong Weigao Group Medical Polymer Co Ltd Class | 4.1761 | 97,500 | 0 | 113,219 |
| 8 | Genscript Biotech Corp Class H | 4.1138 | 43,700 | 0 | 111,529 |
| 9 | Jiangsu Hengrui Medicine Co Ltd | 3.8226 | 7,900 | 0 | 103,635 |
| 10 | China Medical System Holdings Ltd | 3.5730 | 69,900 | 0 | 96,868 |
Country Exposure
Regional Exposure
America
Greater Europe
Greater Asia
Market Classification
Market Capitalization
| Size | % of portfolio |
|---|---|
| Giant | 31.95 |
| Large | 49.02 |
| Medium | 15.89 |
| Small | 3.10 |
| Micro | 0.00 |
Equity Style Box Breakdown
| 0 | 0 | 0 | Large |
| 0 | 0 | 0 | Mid |
| 0 | 0 | 0 | Small |
| Value | Blend | Growth |
Value Measures
Price/Prospective Earnings*
16.3932
Price/Book*
2.3321
Price/Sales*
1.1314
Price/Cash Flow*
13.8888
Dividend Yield*
1.7672
Growth Measures
Long-Term Earnings
12.9977
Historical Earnings
4.8144
Sales Growth
7.6401
Cash-Flow Growth
-4.4358
Book-Value Growth
9.7545
*Forward-looking based on historical data.
Equity Sector
Number of Bond Holdings
0
Bond Statitics
| Detail | Value |
|---|---|
| Average Effective Duration | 0 |
| Average Effective Maturity (Years)* | 0 |
| Average Credit Quality | 0 |
| Average Weighted Coupon* | 0 |
| Average Weighted Price* | 0 |
Bond Style Box Breakdown
| 0 | 0 | 0 | High | Quality |
| 0 | 0 | 0 | Med | |
| 0 | 0 | 0 | Low | |
| Ltd | Mod | Ext | ||
| Interest-Rate Sensitivity | ||||
Credit Quality
| Type | % Bonds |
|---|---|
| N.A | |
Bond Sector
Bond Maturity
| % Bonds | |
|---|---|
| N.A | |
Data Source: Morningstar
© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.
Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.
For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.
